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Abstract
Background: There are over 165,000 mHealth apps currently available to patients, but few have undergone an external quality
review. Furthermore, no standardized review method exists, and little has been done to examine the consistency of the evaluation
systems themselves.
Objective: We sought to determine which measures for evaluating the quality of mHealth apps have the greatest interrater
reliability.
Methods: We identified 22 measures for evaluating the quality of apps from the literature. A panel of 6 reviewers reviewed the
top 10 depression apps and 10 smoking cessation apps from the Apple iTunes App Store on these measures. Krippendorff’s alpha
was calculated for each of the measures and reported by app category and in aggregate.
Results: The measure for interactiveness and feedback was found to have the greatest overall interrater reliability (alpha=.69).
Presence of password protection (alpha=.65), whether the app was uploaded by a health care agency (alpha=.63), the number of
consumer ratings (alpha=.59), and several other measures had moderate interrater reliability (alphas>.5). There was the least
agreement over whether apps had errors or performance issues (alpha=.15), stated advertising policies (alpha=.16), and were easy
to use (alpha=.18). There were substantial differences in the interrater reliabilities of a number of measures when they were
applied to depression versus smoking apps.
Conclusions: We found wide variation in the interrater reliability of measures used to evaluate apps, and some measures are
more robust across categories of apps than others. The measures with the highest degree of interrater reliability tended to be those
that involved the least rater discretion. Clinical quality measures such as effectiveness, ease of use, and performance had relatively
poor interrater reliability. Subsequent research is needed to determine consistent means for evaluating the performance of apps.
Patients and clinicians should consider conducting their own assessments of apps, in conjunction with evaluating information
from reviews.
(JMIR mHealth uHealth 2016;4(1):e15)   doi:10.2196/mhealth.5176
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Introduction
Although there are over 165,000 mHealth apps currently
available, few have undergone an external quality review [1,2].
Currently patients and doctors may find themselves turning to
the Apple iTunes or Android Google Play app stores to identify
which apps may be helpful and avoid those that may be
ineffective or even harmful. The user ratings in these
marketplaces are not designed to be a metric of medical
appropriateness, safety, or efficacy of apps. Quality reviews
conducted by trusted third-parties are important, as it is typically
infeasible for clinicians and patients to evaluate the security,
validity, and efficacy of apps. Third-party reviews have played
an important role in highlighting the quality of enterprise
software (eg, KLAS), consumer electronics (eg, Underwriters’
Laboratories), and even food (eg, Zagat) [3]. Health care
providers and patients have a similar need for quality reviews
of mHealth apps.
There are numerous challenges in rating apps. The availability
of clinical data to guide app recommendations is poor. Medical
research on apps is far behind. For example, while over 20
million American’s suffer from depression each year and there
are over 1000 depression apps in consumer marketplaces [4],
a recent review found only 10 published studies on depression
apps [5]. The United States Food and Drug Administration does
not offer guidance either, noting it does not plan to regulate
many apps that are of low risk [6]. The efforts of professional
and regulatory bodies to curate apps have also been
disappointing, with the recent news of the shutdown of the
British National Health Service’s Health App Library [7] after
a study revealed that many apps accredited actually transmitted
medical data in an unsecure manner and that several lacked
privacy policies [8], among other concerns. Finally, any app
rating system would have to be continually updated, as apps
themselves are often upgrading and changing.
Despite the substantial challenges in rating apps, there have
been important efforts to begin to understand how to best
approach the problem. Several methodologies have been
proposed for evaluating the quality of apps [9-11], although no
standardized method exists, and little has been done to examine
the consistency of the evaluation systems themselves.
One methodology of note that was introduced after the design
of this study is the Mobile App Rating Scale (MARS), a 23-item
scale that demonstrates strong internal consistency and interrater
reliability in a research study involving 2 expert raters [12].
However, like many scales, its validity is still uncertain and it
has not been widely adopted yet. Furthermore, there have been
both generalized frameworks [11] and specialty-specific efforts
[13-15] that use inconsistent measures to evaluate quality.
However, it is unclear how any of these methodologies and
scales hold up in real-world clinical practice and when used by
non-expert raters. Given the rapid growth in the number of
mHealth apps and the constant updating of existing apps, it
makes sense that clinicians will need to utilize and apply app
ratings [2].
The need for quality measures of mHealth apps will become
increasingly important as more patients ask physicians for app
recommendations. The lack of standardized quality measures
is concerning, as app use carries risk and can lead to adverse
outcomes for both patients and clinicians. Poorly designed apps
may offer ineffective care or even cause harm [16]. Clinicians
may place themselves at legal, professional, and ethical risk if
digital technologies are recommended inappropriately [17].
Furthermore, if apps are eventually to be prescribed by providers
and reimbursed by payers, there must be a robust way to
evaluate the safety and effectiveness of apps [18]. Standardized
measures with high interrater reliability are needed to evaluate
mHealth apps. Nonetheless, without standardized measures for
evaluating app outcomes, clinicians have difficulty comparing
the quality of apps when making recommendations. When
measures are available, quality measures with low interrater
reliability are problematic, as ratings produced are not
necessarily reflective of what would be experienced by other
raters or users.
In order to foster the development of standardized app quality
measures, we seek to evaluate the interrater reliability of existing
measures [19] and provide direction on which should be
incorporated in standardized app evaluation systems. In addition,
we seek to determine whether the interrater reliability of the
measures is consistent across multiple types of apps, and which
of these measures may be the best to incorporate into app
evaluation systems and tools. As mHealth apps are used for a
wide range of purposes, it is important to understand which
quality measures consistently perform with high interrater
reliability, regardless of the nature of the apps being evaluated.
Methods
Selection of Apps
To evaluate whether the interrater reliability of quality measures
is consistent across multiple types of apps, we evaluated the top
10 search results displayed by the US Apple iTunes App Store
for iOS (iPhone, iPod Touch, and iPad) returned by queries for
“depression” and “smoking” in March 2015 (see Multimedia
Appendix 1). While rankings are in constant flux as apps are
updated and rated by app store users, the apps selected reflect
those most visible to users seeking assistance at the time of
selection. This was done to increase the realism of the sample,
as users without pre-existing knowledge of which apps to seek
are likely to pick those they see first.
Depression and smoking cessation (hereafter referred to as
“smoking”) categories were selected because they are common
issues, cause significant comorbidity, and have been the targets
of many early mobile phone interventions that are directly
marketed to patients [20-22]. In 2013, over 15 million US adults
suffered from depression (6.7% of the population) [23], and
over 42 million Americans smoked cigarettes (nearly 18% of
the population) [24]. Also, a recent study suggested that when
considering apps by treatment type, mental health and behavioral
disorders are the largest sector—more numerous than both
cardiac and cancer-focused apps [25]. The clinical evidence
supporting apps in these categories has the potential to be more
robust than supporting apps managing other indications [26].
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Selection of App Quality Measures
We reviewed existing mHealth app ratings sites and the literature
to identify app evaluation measures. At this time, there is no
gold standard for rating apps and no central repository of app
ratings. While the list of measures evaluated may not be
definitive, it is varied and reflective of the practice of a number
of organizations. The Anxiety and Depression Association of
America (ADAA) and PsyberGuide were two websites that
were used as sources of measures. The ADAA rates apps on
ease of use, perceived effectiveness, personalization,
interactiveness/feedback, and research evidence on a 5-point
scale [27]. PsyberGuide evaluates the basis of the research
behind the app, the source of the funding for the research, the
specificity of the proposed intervention, the number of consumer
ratings, whether a product advisory board with clinical thought
leadership exists, and whether the app has been revised within
the past 12 months [28].
Although the ADAA and PsyberGuide measures were the best
characterized, we also used measures cited in the literature,
including whether an app has password protection and
import/export capabilities [29], whether an app is uploaded by
a health care agency versus a non-health care agency [30],
whether the developer is contactable and the advertising policy
is clearly stated [31], whether there is a lack of errors or
hang-ups and continuous access to the data [32], whether an
app discloses potential risks, and whether it offers technical
support or help [33].
mHealth apps must be safe, accurate, effective, secure, and
protect privacy to be used by patients, recommended by health
care professionals, and eventually reimbursed [2]. While it is
difficult to assess the safety or accuracy of an app without an
in-depth review, it is possible to rapidly determine whether an
app has security measures such as password protection and
encryption, and privacy measures such as an explicit privacy
policy. Likewise, it can be difficult to assess the effectiveness
of an app. We included three measures of effectiveness:
perceived effectiveness, research evidence base for an app, and
whether or not the app claimed that the effectiveness was tested.
Evaluating perceived effectiveness required the reviewers to
subjectively evaluate the app against its stated objective, whereas
the evidence base and statement of effectiveness made by the
app were evaluated based on discrete findings. Table 1
summarizes all of the app quality measures included in this
study and presents the terms of each measure exactly as defined
for reviewers.
App Review Process
Each app was rated by up to 6 reviewers. Reviewers were an
interdisciplinary group including clinicians, technology experts,
and researchers; all are study co-authors. Reviewers were
instructed to rate all 20 apps (Multimedia Appendix 1) on all
22 measures (see Table 1). Each reviewer reviewed a minimum
of 17 of the 20 apps on each of the 22 measures.
Reviews were conducted between March and May 2015. All
apps were reviewed running on iPhones. Reviewers did not
discuss their reviews with each other to ensure that each rating
was independent. For each of the apps, the reviewers were
provided a copy of Table 1, with space for their ratings.
Reviewers were not provided with any additional training in
the review methodology in order to best approximate what
would occur if the reviewers read about the metrics
independently. No human subjects were used in this study.
Results are reported in aggregate only, not at the app level.
Reviewers were asked to download the apps to their personal
iPhones and then to assign values to each of the measures using
only information provided within the app itself and in the iTunes
App Store for iOS. As reviewers used their personal iPhones,
it is likely that multiple hardware and operating system
configurations were used during the review process. Although
reviewers were asked to spend several minutes examining each
app, they were not asked to use the apps in a realistic manner.
Realistic use would not have been feasible, as the reviewers
were selected for their expertise in mHealth, rather than for their
history of depression or smoking. This short duration of use
simulates what is likely to occur when apps are evaluated by
experts without a personal need for the apps in question.
After reviews were completed, the reviewers were sent
screenshots from each of the apps and asked to verify that the
apps they reviewed were the same as the ones shown. One
reviewer was unable to review one smoking app and
misidentified a second smoking app and one depression app.
In the cases where apps were misidentified, they were treated
as missing. Each measure was applied up to 120 times (20 apps
rated by 6 reviewers). However, due to app identification issues
and occasional cases of reviewer uncertainty about the proper
rating to apply, each measure was only applied between 109
and 112 times, yielding data completeness between 91% and
93%, depending on the measure (see Table 2).
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Table 1. mHealth app quality measures evaluated.
DefinitionsRangeSourceMeasure
5=very easy; 1=very difficult1-5ADAAEase of use
5=highly likely; 1=highly unlikely1-5ADAAEffectiveness (Perceived)
5=complete ability; 1=no ability1-5ADAAPersonalization
5=very interactive, helpful feedback; 1=not interactive, no feedback1-5ADAAInteractiveness/Feedback
3=data from at least one randomized controlled trial; 2=data from at least
one non-randomized non-controlled trial; 1=data from an open study; 0=no
data provided
0-3 (and
1-5a)
PsyberGuide (&
ADAAa)
Basis of research
2=research supported exclusively by government agency or non-profit
organizations; 1=research supported in full or part by for-profit organiza-
tions; 0=no data provided
0-2PsyberGuideSource of funding for research
3=the application is designed to improve a specific condition or symptom;
2=the application is designed to help with non-specific items such as
“mood” or “brain fitness”; 1=the application is designed to track and
monitor items such as symptom severity or medication; 0= no data provided
1-3PsyberGuideSpecificity of intervention
3=ratings exist from >50 users; 2=ratings exist from 25-50 users; 1=fewer
than 25 user ratings
1-3PsyberGuideNumber of consumer ratings
1=yes; 0=no0-1PsyberGuideProduct advisory support
1=yes; 0=no0-1PsyberGuideSoftware support
1=yes; 0=no0-1Kharrazi et al (2012)Password protection
1=yes; 0=no0-1Kharrazi et al (2012)Import/export capabilities
1=yes; 0=no0-1Pandey et al (2012)Uploaded by health care agency
1=yes; 0=no0-1Powell et al (2014)Encryption
1=yes; 0=no0-1Powell et al (2014)Explicit privacy policy
1=yes; 0=no0-1Powell et al (2014)Effectiveness tested (claimed by app)
1=yes; 0=no0-1LewisDeveloper contactable
1=yes; 0=no0-1LewisAdvertising policy stated
1=yes; 0=no0-1Martinez-Perez et al
(2013)
Errors and performance issues
1=yes; 0=no0-1Martinez-Perez et al
(2013)
Continuous availability of data
1=yes; 0=no0-1Ferrero-Álvarez-
Rementería et al
(2013)
Discloses potential risks
1=yes; 0=no0-1Ferrero-Álvarez-
Rementería et al
(2013)
Offers technical support or help
a1=no research evidence; 5=ample research evidence; ADAA scale not used.
Data Analysis
Interrater reliability for each app quality measure was evaluated
for both the depression and smoking categories separately, as
well as for the two categories combined. Krippendorff’s alpha
was used to assess interrater reliability, as it allows for ordinal
ratings to be assigned, can be used with an unlimited number
of reviewers, is robust to missing data, and is superior to
Cohen’s kappa [34-37]. An alpha ˃.667 was used to indicate
agreement [35]. A negative alpha indicates less agreement than
would be expected by chance and indicates that there may have
been inconsistencies in how measures were applied.
Krippendorff’s alpha was calculated using the krippalpha
module for Stata [38].
Results
Table 2 summarizes the interrater reliability of app quality
measures overall and by application type, that is, depression or
smoking. The level of data completeness for each measure is
additionally reported. When considered in aggregate, only the
measure for interactiveness and feedback reached our threshold
for agreement. However, a number of other measures came
close, with alphas ˃ .5: presence of password protection, whether
the app was uploaded by a health care agency, number of
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consumer ratings, whether the app had an explicit privacy policy,
whether the app had encryption, whether the app was based on
research, and whether the app had product advisory support.
There was the least agreement over whether apps had errors or
performance issues, stated advertising policies, were easy to
use, made claims about effectiveness being tested, and made
data continuously available.
When ratings for depression apps were evaluated independently,
both interactiveness and feedback measure and the password
protection measure reached our threshold for agreement.
Meanwhile, when ratings for smoking apps were evaluated
independently, there was perfect agreement (alpha=1) on
whether the apps were uploaded by health care agencies and
whether the apps were encrypted. There were also differences
in app quality measure reliability between the depression and
smoking apps. The difference in alpha when applied to
depression versus smoking apps was greater than .4 for the
following measures: encryption, import/export capabilities, and
specificity of intervention.
Table 2. Interrater reliability of depression and smoking apps by measure.
Completeness, %Interrater reliability (Krippendorff’s alpha)Measure
SmokingDepressionAggregate
930.670.690.69Interactiveness/Feedback
930.370.750.65Password protection
931.000.600.63Uploaded by health care agency
930.420.740.59Number of consumer ratings
930.380.730.55Explicit privacy policy
921.000.510.54Encryption
930.440.550.53Basis of research
930.440.550.52Product advisory support
930.350.500.45Offers technical support or help
930.440.420.44Software support
930.040.470.42Import/export capabilities
930.360.380.42Developer contactable
930.490.380.42Personalization
91-0.140.330.36Specificity of intervention
920.590.220.36Source of funding for research
930.000.230.31Discloses potential risks
930.120.430.30Effectiveness (Perceived)
930.090.220.27Continuous availability of data
930.340.110.21Effectiveness tested (claimed by app)
930.230.090.18Ease of use
930.20-0.040.16Advertising policy stated
930.030.280.15Errors and performance issues
Discussion
Principal Findings
Overall, we found only a few measures with high interrater
reliability; most of the app measures had poor interrater
reliability. The measures with the highest degree of interrater
reliability tended to involve the least rater discretion. For
instance, the presence of encryption and whether or not the app
was uploaded by a health care agency can be assessed largely
on a factual basis, while the ease of use measure is subject to
interpretation. Surprisingly, the presence of
interactiveness/feedback, the measure with the greatest degree
of interrater reliability overall, was a subjective measure. This
suggests that raters were able to come to directional agreement
about interactiveness/feedback. While the measure was
subjective, it may have led to more consistent ratings than many
of the objective measures, as it could be assessed by examining
an app holistically rather than by correctly identifying a single
feature. While the presence or absence of a feature can be
objectively determined, it can also more easily be missed by a
reviewer performing a rapid review.
For mHealth apps to be successfully used in clinical practice,
they need to be safe and effective. Reviewers had moderate
agreement on security/privacy measures, including the presence
of password protection, explicit privacy policy, and encryption.
Perceived effectiveness had low interrater reliability suggesting
that even finding agreement on which apps may actually offer
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effectiveness is challenging. Effectiveness tested as claimed by
the app also had low interrater reliability. The basis of research
behind an app had better interrater reliability and may be a more
reliable indicator of effectiveness than perceived effectiveness.
Due to the current limited data on the efficacy of most apps,
relying on the research base alone is difficult at this time. Given
the increasing shift to value-based care with rewards for
delivering high-quality care based on evidence-based principles,
subsequent research may examine ways of more consistently
evaluating the performance of apps on these useful dimensions.
Automated outcomes reporting may be a means of gauging
effectiveness, and automated crash reporting may be a means
of gauging performance [3].
Beyond effectiveness, other clinically important measures, such
as ease of use and performance issues, also had relatively poor
interrater reliability. Reviewers rated perceived effectiveness
and ease of use with 5-point Likert scales in this study. More
robust measures are needed for these important measures. The
validated System Usability Scale [39] could be considered to
measure ease of use.
We also found differences in the performance of measures
between the smoking and depression apps. Depression apps had
much higher interrater reliability on the presence of password
protection than did smoking apps. Several of the smoking apps
had passwords associated with the social network functionality,
but not the rest of the app, which may have been a source of
ambiguity for reviewers. The measures on whether an app was
uploaded by a health care agency and contained encryption had
perfect agreement for smoking apps, but not for depression
apps. Therefore, there may be fundamental differences between
categories of apps that impact the interrater reliability of
measures. As a result of this heterogeneity, it may be necessary
to validate the interrater reliability of measures separately for
each category of apps.
While the challenge of rating mHealth apps may be new, issues
related to rating scales are not new to health care. Measuring
quality of care of hospitals and health care systems is
challenging, and there is also at times little consensus between
various metrics [40]. Perhaps organizations seeking to rate apps
can learn from the quality improvement and safety literature to
understand how to best implement effective rating scales.
Overall, the results suggest a need for great caution when
assigning and interpreting app ratings (see Table 3).
Organizations rating apps should create robust measures with
clearly defined criteria to ensure consistency. They should then
test the interrater reliability and validity of their measures and
utilize only ones with high levels of agreement. The reliability
of reviews can further be improved by carefully training
reviewers on how to consistently apply the measures. Consumers
of reviews—both patients and clinicians—should interpret
reviews cautiously, especially if they rely on measures that have
not been shown to be reliable and valid. Clinicians may wish
to use reviews as a mechanism for selecting potentially
beneficial apps and then carefully test apps before
recommending them to patients to ensure that the reviewers’
definitions of quality are consistent with their own. There may
likewise be value in discussing apps with colleagues before
recommending them, as it appears that clinicians may not
identify quality issues consistently. Even in this era of digital
health, clinician judgment may still be the best available tool
for evaluating apps. Table 3 summarizes lessons learned from
our app review.
Table 3. Key lessons learned for clinicians, patients, and app reviewers.
For app reviewersFor patientsFor clinicians
Use previously validated measures with high inter-
rater reliability, if available
Interpret mHealth app reviews cau-
tiously
Interpret mHealth app reviews cautiously, especially
if measures have not been validated
Train reviewers on the measures using standardized
specifications
Consult with your health care
provider or another trusted source
Consider reviewing apps personally before recommend-
ing apps to patients
Involve patients or reviewers with the condition of
interest in the reviews
Consider discussing apps with colleagues
Record the name and version of the app being re-
viewed, as well as the date of the review
Use clinical judgment as a tool for evaluating apps
Limitations
While this study provides some initial conclusions about
interrater reliability, it may have limited generalizability and
does not address measure validity. Only 20 apps in two
categories were evaluated, and some differences were found in
the interrater reliability of the measures across categories. We
included only Apple iOS apps for iPhone devices; Android-only
apps were not considered. Furthermore, the apps selected may
not be representative of their respective categories.
The app review methods used may have contributed to low
measure interrater reliability. The measures of review
completeness suggest that reviewers sometimes had issues
determining the appropriate ratings for measures or finding the
right apps. Future researchers and physicians prescribing apps
should consider providing direct links to apps to ensure that
there is no confusion. It is easy to imagine situations where
physicians recommend apps to patients by name, and then
patients are unable to properly identify apps as other available
apps have similar titles. Likewise, detailed measure definitions
and additional reviewer training may help future reviewers
provide more complete ratings with confidence. Nonetheless,
each measure was applied 109 or more times, out of a potential
total of 120 applications, indicating that in the majority of cases,
reviewers were able to properly identify the app and apply a
rating for the measure. Further, there may be idiosyncrasies in
the rating behavior of the 6 reviewers who participated.
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Of note, we did not include any patient ratings in our review
process. In the future, it would be interesting to compare the
ratings of patients versus expert reviewers. It is possible that
patients with depression or tobacco use disorder may have been
able to identify salient app features that our reviewers missed.
Further research is needed in this important area.
Last, reviews were performed over a 3-month period between
March and May 2015, and it is possible that the apps themselves
evolved through updates during the period in a way that
impacted the reviews. While this issue impacts interrater
reliability, it also impacts the usefulness of reviews, as patients
and clinicians may sometimes have to rely on reviews that were
conducted on prior versions of apps.
Conclusions
Our study suggests that some measures have greater interrater
reliability than others and that the relative interrater reliability
of measures is not robust across categories of mHealth apps.
Unfortunately, the research also suggests that some of the most
clinically useful measures—effectiveness and ease of use—have
relatively poor interrater reliability. Organizations seeking to
rate apps should consider the interrater reliability of the metrics
they are utilizing and select metrics with lower levels of
ambiguity. Clinician judgment thus remains critical in evaluating
and understanding the clinical role of mobile phone apps.
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